Pneumococcal vaccine responses in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance

Trials in Vaccinology

Volumn 2, Issue 1, 2013, Pages 31-38

  Karlsson, Johanna ^a,b   Hogevik, Harriet ^a,b   Andersson, Kerstin ^b   Roshani, Leyla ^a   Andréasson, Björn ^a,b   Wennerås, Christine ^b  

^a NU Hospital Organization   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Immunogenicity; MGUS; Myeloma; Opsonophagocytosis; Pneumococcal vaccines; Waldenstrom

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUDARABINE; IMMUNOGLOBULIN G ANTIBODY; MELPHALAN; PNEUMOCOCCUS VACCINE; PREDNISONE; STEROID; THALIDOMIDE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ASSAY; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOGENICITY; IMMUNOGLOBULIN DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MULTIPLE ORGAN FAILURE; OPSONOPHAGOCYTOSIS ASSAY; PLEURISY; PNEUMOCOCCAL SEPTICEMIA; PRIORITY JOURNAL; SEPTICEMIA; SEROTYPE; SINGLE DRUG DOSE; WALDENSTROEM MACROGLOBULINEMIA;

EID: 84889084599     PISSN: None     EISSN: 18794378     Source Type: Journal    
DOI: 10.1016/j.trivac.2013.09.001     Document Type: Article

References (35)

1. J. Blade, and L. Rosinol Renal, hematologic and infectious complications in multiple myeloma Best Pract. Res. Clin. Haematol. 18 2005 635 652 (Pubitemid 40984119)
2. M. Nucci, and E. Anaissie Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents Clin. Infect. Dis. 49 2009 1211 1225
3. B.M. Augustson, G. Begum, J.A. Dunn, N.J. Barth, F. Davies, and G. Morgan Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party J. Clin. Oncol. 23 2005 9219 9226
4. R. Garcia-Sanz, S. Montoto, A. Torrequebrada, A.G. de Coca, J. Petit, and A. Sureda Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases Br. J. Haematol. 115 2001 575 582 (Pubitemid 34019184)
5. S.Y. Kristinsson, M. Bjorkholm, T.M. Andersson, S. Eloranta, P.W. Dickman, and L.R. Goldin Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study Haematologica 94 2009 1714 1720
6. S.Y. Kristinsson, M. Tang, R.M. Pfeiffer, M. Bjorkholm, L.R. Goldin, and C. Blimark Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study Haematologica 97 2012 854 858
7. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 61 (2012) 816-819.
8. S. Moberley, J. Holden, D.P. Tatham, and R.M. Andrews Vaccines for preventing pneumococcal infection in adults Cochrane Database Syst. Rev. 2013 CD000422
9. A. Huss, P. Scott, A.E. Stuck, C. Trotter, and M. Egger Efficacy of pneumococcal vaccination in adults: a meta-analysis CMAJ 180 2009 48 58
10. R.M. Hargreaves, J.R. Lea, H. Griffiths, J.A. Faux, J.M. Holt, and C. Reid Immunological factors and risk of infection in plateau phase myeloma J. Clin. Pathol. 48 1995 260 266
11. J.D. Robertson, K. Nagesh, S.N. Jowitt, M. Dougal, H. Anderson, and K. Mutton Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma Br. J. Cancer 82 2000 1261 1265 (Pubitemid 30145342)
12. J. Karlsson, B. Andreasson, N. Kondori, E. Erman, K. Riesbeck, and H. Hogevik Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance Clin. Vaccine Immunol. 18 2011 969 977
13. J.H. Antin, E.C. Guinan, D. Avigan, R.J. Soiffer, R.M. Joyce, and V.J. Martin Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation Biol. Blood Marrow Transplant. 11 2005 213 222 (Pubitemid 40287920)
14. C. Cordonnier, M. Labopin, V. Chesnel, P. Ribaud, R. De La Camara, and R. Martino Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation Clin. Infect. Dis. 48 2009 1392 1401
15. A.M. van der Velden, A.M. Claessen, H. van Velzen-Blad, M.R. de Groot, M.H. Kramer, and D.H. Biesma Vaccination responses and lymphocyte subsets after autologous stem cell transplantation Vaccine 25 2007 8512 8517 (Pubitemid 350192048)
16. D.C. Molrine, J.H. Antin, E.C. Guinan, R.J. Soiffer, K. MacDonald, and R. Malley Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation Blood 101 2003 831 836 (Pubitemid 36139347)
17. P. Ljungman, C. Cordonnier, H. Einsele, J. Englund, C.M. Machado, and J. Storek Vaccination of hematopoietic cell transplant recipients Bone Marrow Transplant. 44 2009 521 526
18. E.S. Jaffe, N.L. Harris, H. Stein, and J.W. Vardiman WHO classification of tumours 3rd ed. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001 IARC Press Lyon
19. H.B. Konradsen, U.B. Sorensen, and J. Henrichsen A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies J. Immunol. Methods 164 1993 13 20
20. R.L. Burton, and M.H. Nahm Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies Clin. Vaccine Immunol. 13 2006 1004 1009 (Pubitemid 44518968)
21. N. Ekstrom, C. Virta, K. Jousimies et al., Establishment of the multiplexed opsonization assay (MOPA4) at KTL (P3-133), in:: 6th International Symposium on Pneumococci and Pneumococcal Diseases, 2008.
22. L. Eriksson, H. Antti, J. Gottfries, E. Holmes, E. Johansson, and F. Lindgren Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm) Anal. Bioanal. Chem. 380 2004 419 429
23. R. Meisel, L. Kuypers, U. Dirksen, R. Schubert, B. Gruhn, and G. Strauss Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation Blood 109 2007 2322 2326 (Pubitemid 46425870)
24. P. Lesprit, G. Pedrono, J.M. Molina, C. Goujard, P.M. Girard, and N. Sarrazin Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults AIDS 21 2007 2425 2434 (Pubitemid 350145174)
25. S.B. Manoff, C. Liss, M.J. Caulfield, R.D. Marchese, J. Silber, and J. Boslego Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 ≥ years J. Infect. Dis. 201 2010 525 533
26. L.L. Hammitt, L.R. Bulkow, R.J. Singleton, J.P. Nuorti, K.B. Hummel, and K.M. Miernyk Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness Vaccine 29 2011 2287 2295
27. World Health Organization Expert Committee on Biological Standardization. Pneumococcal conjugate vaccine: recommendations for production and quality control of pneumococcal conjugate vaccines. Available at: < http://www.who.int/biologicals/pneumococcal-conjugate-Vaccines-Recomm-Nov-2003 >; 2003 (accessed 01.09.08).
28. D. Goldblatt, J. Southern, N. Andrews, L. Ashton, P. Burbidge, and S. Woodgate The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years Clin. Infect. Dis. 49 2009 1318 1325
29. S. Romero-Steiner, D.M. Musher, M.S. Cetron, L.B. Pais, J.E. Groover, and A.E. Fiore Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity Clin. Infect. Dis. 29 1999 281 288 (Pubitemid 29380185)
30. B. Simell, A. Vuorela, N. Ekstrom, A. Palmu, A. Reunanen, and S. Meri Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis Vaccine 29 2011 1929 1934
31. P. Balmer, R. Borrow, J. Findlow, R. Warrington, S. Frankland, and P. Waight Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine Clin. Vaccine Immunol. 14 2007 1442 1450 (Pubitemid 350304038)
32. S. Berg, B. Trollfors, E. Persson, E. Backhaus, P. Larsson, and E. Ek Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics Scand. J. Infect. Dis. 38 2006 427 432 (Pubitemid 44150775)
33. C. Cordonnier, M. Labopin, K.U. Jansen, M. Pride, V. Chesnel, and E. Bonnet Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell transplant Bone Marrow Transplant. 45 2010 1423 1426
34. D. Kumar, M.H. Chen, B. Welsh, D. Siegal, I. Cobos, and H.A. Messner A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients Clin. Infect. Dis. 45 2007 1576 1582 (Pubitemid 351411841)
35. E.A. Clutterbuck, R. Lazarus, L.M. Yu, J. Bowman, E.A. Bateman, and L. Diggle Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells J. Infect. Dis. 205 2012 1408 1416